Cargando…
Probiotics and rifaximin for the prevention of travelers’ diarrhea: A systematic review and network meta-analysis
Probiotics and rifaximin are treatments for gut microbiota dysbiosis in patients with traveler’s diarrhea (TD), and they both proved beneficial for the prevention of TD. However, comparative effectiveness research between them has not been performed. A systematic review and network meta-analysis are...
Autores principales: | Fan, Hao, Gao, Lei, Yin, Zidan, Ye, Sheng, Zhao, Hua, Peng, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542755/ https://www.ncbi.nlm.nih.gov/pubmed/36221413 http://dx.doi.org/10.1097/MD.0000000000030921 |
Ejemplares similares
-
A meta-analysis of the effects of probiotics and synbiotics in children with acute diarrhea
por: Yang, Bo, et al.
Publicado: (2019) -
Is rifaximin better than nonabsorbable disaccharides in hepatic encephalopathy?: A meta-analysis
por: Cheng, Junxiong, et al.
Publicado: (2021) -
Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials
por: Li, Jun, et al.
Publicado: (2016) -
The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea
por: Koo, Hoonmo L, et al.
Publicado: (2009) -
Effectiveness of rifaximin and fluoroquinolones in preventing travelers’ diarrhea (TD): a systematic review and meta-analysis
por: Alajbegovic, Sanjin, et al.
Publicado: (2012)